StockData
Nu Skin Enterprises, Inc. logo

Nu Skin Enterprises, Inc. (NUS) stock

NUSNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/3069% below fair value
$3.78−0.15 (-3.82%)

Close on Nov 17, 2026Market cap $184.00MP/E –Yield –

Nu Skin Enterprises operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Nu Skin Enterprises's operating income for the twelve months ending Sep 30, 2026 was -$26.96M. For fiscal 2025 it was $65.76M. Over ten years it grew -12.3% a year on average. The highest annual figure on record is $554.11M in fiscal 2013.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$65.76M–
FY2024Dec 31, 2024-$151.59M-414.0%
FY2023Dec 31, 2023$48.27M-56.5%
FY2022Dec 31, 2022$110.85M-52.6%
FY2021Dec 31, 2021$233.99M-9.2%
FY2020Dec 31, 2020$257.56M-3.7%
FY2019Dec 31, 2019$267.43M+11.0%
FY2018Dec 31, 2018$240.86M-12.2%
FY2017Dec 31, 2017$274.48M+18.8%
FY2016Dec 31, 2016$231.10M-5.6%
FY2015Dec 31, 2015$244.70M-30.5%
FY2014Dec 31, 2014$352.19M-36.4%
FY2013Dec 31, 2013$554.11M+62.6%
FY2012Dec 31, 2012$340.84M+45.8%
FY2011Dec 31, 2011$233.74M+7.7%
FY2010Dec 31, 2010$217.06M+46.9%
FY2009Dec 31, 2009$147.71M+17.8%
FY2008Dec 31, 2008$125.43M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$5.09M-76.5%
Q2 FY2026Jun 30, 2026-$59.32M-292.7%
Q1 FY2026Mar 31, 2026$4.03M–
Q4 FY2025Dec 31, 2025$23.24M–
Q3 FY2025Sep 30, 2025$21.64M+18.7%
Q2 FY2025Jun 30, 2025$30.78M–
Q1 FY2025Mar 31, 2025-$9.90M-212.3%
Q4 FY2024Dec 31, 2024-$53.08M-430.5%
Q3 FY2024Sep 30, 2024$18.23M–
Q2 FY2024Jun 30, 2024-$125.56M-395.4%
Q1 FY2024Mar 31, 2024$8.82M-45.1%
Q4 FY2023Dec 31, 2023$16.06M-41.5%
Q3 FY2023Sep 30, 2023-$26.37M–
Q2 FY2023Jun 30, 2023$42.51M-17.5%
Q1 FY2023Mar 31, 2023$16.06M-69.2%
Q4 FY2022Dec 31, 2022$27.46M+35.1%
Q3 FY2022Sep 30, 2022-$20.28M-131.0%
Q2 FY2022Jun 30, 2022$51.53M-39.6%
Q1 FY2022Mar 31, 2022$52.15M-17.1%
Q4 FY2021Dec 31, 2021$20.32M-77.1%
Q3 FY2021Sep 30, 2021$65.38M-11.9%
Q2 FY2021Jun 30, 2021$85.38M+47.0%
Q1 FY2021Mar 31, 2021$62.91M+72.1%
Q4 FY2020Dec 31, 2020$88.70M+62.2%
Q3 FY2020Sep 30, 2020$74.23M+6.2%
Q2 FY2020Jun 30, 2020$58.07M-21.7%
Q1 FY2020Mar 31, 2020$36.57M-46.7%
Q4 FY2019Dec 31, 2019$54.68M+196.7%
Q3 FY2019Sep 30, 2019$69.89M-13.4%
Q2 FY2019Jun 30, 2019$74.20M-10.3%
Q1 FY2019Mar 31, 2019$68.65M+16.4%
Q4 FY2018Dec 31, 2018$18.43M-81.4%
Q3 FY2018Sep 30, 2018$80.68M+25.3%
Q2 FY2018Jun 30, 2018$82.76M+27.8%
Q1 FY2018Mar 31, 2018$58.99M+27.5%
Q4 FY2017Dec 31, 2017$99.12M+63.1%
Q3 FY2017Sep 30, 2017$64.36M–
Q2 FY2017Jun 30, 2017$64.74M–
Q1 FY2017Mar 31, 2017$46.26M–
Q4 FY2016Dec 31, 2016$60.78M–

More Nu Skin Enterprises figures

See a number that looks wrong?